{"title":"Trends, Patient Outcomes, and Resource Utilization Associated with Surgical Staplers During Robotic Sleeve Gastrectomy.","authors":"I-Wen Pan, Zasim Azhar Siddiqui","doi":"10.2147/CEOR.S525137","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Robotic platforms are commonly used for sleeve gastrectomy, despite the high capital costs and little understanding of the roles of platform-specific consumables and standard surgical alternatives in clinical outcomes and healthcare resource utilization. This study evaluates the trend, the effectiveness (outcomes) and efficiency (resource utilization) of different types of surgical staplers used in robotic sleeve gastrectomy (RSG).</p><p><strong>Patients and methods: </strong>This was a retrospective observational cohort study analyzing data from the PINC AI™ Healthcare Data database. Patients were included if they underwent elective, inpatient, primary sleeve gastrectomy performed using the Intuitive Surgical robotic system (Sunnyvale, CA) with either a bedside stapler (BS, Signia™, Endo-GIA™, or Tri-staple™) or a robotic stapler (RS, Sureform™). The primary outcome measures included inpatient costs, complications, operating room time (ORT), length of stay (LOS), and intensive care unit visits. Outcomes were analyzed using bivariate analyses, multivariable generalized linear models (GLM), and propensity-score matching (PSM).</p><p><strong>Results: </strong>Of 18,892 total RSG procedures that met eligibility criteria, robotic staplers were used in 15,152 procedures (80.2%) and bedside staplers were used in 3740 (19.8%). While RSG increased dramatically during the period, RS were shown to be associated with a greater risk of blood transfusion compared to bedside staplers both in a GLM [0.5% (BS) vs 0.7% (RS); Odds ratio (OR): 1.55; 95% confidence interval (CI): 1.02-2.36; p = 0.04] and after PSM [0.3% (BS) vs 0.9% (RS); OR: 3.02; 95% CI: 1.35-6.73; p = 0.007]. Bedside staplers were associated with total costs reduction [mean cost savings: $3084; 95% CI: $2860 - $3309; p < 0.001] and shorter ORT (21 minutes; 95% CI: 18.6-23.5; p < 0.001) compared to robotic staplers. Difference in LOS was not clinically significant.</p><p><strong>Conclusion: </strong>When used during RSG, bedside staplers are cost-saving, with equivalent or better clinical outcomes and reduced resource utilization compared to robotic staplers.</p>","PeriodicalId":47313,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"17 ","pages":"561-569"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379977/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ClinicoEconomics and Outcomes Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/CEOR.S525137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Robotic platforms are commonly used for sleeve gastrectomy, despite the high capital costs and little understanding of the roles of platform-specific consumables and standard surgical alternatives in clinical outcomes and healthcare resource utilization. This study evaluates the trend, the effectiveness (outcomes) and efficiency (resource utilization) of different types of surgical staplers used in robotic sleeve gastrectomy (RSG).
Patients and methods: This was a retrospective observational cohort study analyzing data from the PINC AI™ Healthcare Data database. Patients were included if they underwent elective, inpatient, primary sleeve gastrectomy performed using the Intuitive Surgical robotic system (Sunnyvale, CA) with either a bedside stapler (BS, Signia™, Endo-GIA™, or Tri-staple™) or a robotic stapler (RS, Sureform™). The primary outcome measures included inpatient costs, complications, operating room time (ORT), length of stay (LOS), and intensive care unit visits. Outcomes were analyzed using bivariate analyses, multivariable generalized linear models (GLM), and propensity-score matching (PSM).
Results: Of 18,892 total RSG procedures that met eligibility criteria, robotic staplers were used in 15,152 procedures (80.2%) and bedside staplers were used in 3740 (19.8%). While RSG increased dramatically during the period, RS were shown to be associated with a greater risk of blood transfusion compared to bedside staplers both in a GLM [0.5% (BS) vs 0.7% (RS); Odds ratio (OR): 1.55; 95% confidence interval (CI): 1.02-2.36; p = 0.04] and after PSM [0.3% (BS) vs 0.9% (RS); OR: 3.02; 95% CI: 1.35-6.73; p = 0.007]. Bedside staplers were associated with total costs reduction [mean cost savings: $3084; 95% CI: $2860 - $3309; p < 0.001] and shorter ORT (21 minutes; 95% CI: 18.6-23.5; p < 0.001) compared to robotic staplers. Difference in LOS was not clinically significant.
Conclusion: When used during RSG, bedside staplers are cost-saving, with equivalent or better clinical outcomes and reduced resource utilization compared to robotic staplers.